Rohde Stefan, Kovács Adorján F, Berkefeld Joachim, Turowski Bernd
Department of Neuroradiology, Ruprecht Karls-University Medical School, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Neuroradiology. 2006 Jun;48(6):415-21. doi: 10.1007/s00234-006-0072-5. Epub 2006 Apr 12.
The aim of the study was to evaluate the feasibility and consistency of CT-based tumor volumetry in patients with early carcinoma of the oral cavity and the oropharynx before and after intraarterial (IA) chemotherapy, comparing these data with clinical remission rates.
Included in the study were 61 patients (mean age 59.3 years; 47 men) with histologically proven small carcinoma of the oral cavity or the oropharynx (local tumor stages T1/2). Patients received IA chemotherapy with high-dose cisplatin as part of a multimodal therapeutic regimen and underwent both clinical and radiological examination before and 4 weeks after local chemotherapy.
Clinical evaluation of tumor response was possible in all patients (61/61). Radiological assessment of tumor volume was feasible in 42 of 61 patients (69%), but failed in 19 (31%) due to the absence of deep tumoral spread, lack of contrast enhancement or severe dental artifacts. Patients in whom evaluation was possible according to volumetric and clinical criteria revealed comparable remission rates: overall response 54.8% versus 52.4%, stable disease 40.4% versus 47.6%, and tumor progression 4.8% versus 0.0%.
Because volume calculation was not feasible in approximately one-third of the patients, it cannot be recommended as a reliable indicator for treatment response in patients with small carcinoma of the oral cavity.
本研究旨在评估基于CT的肿瘤体积测量法在口腔和口咽早期癌患者动脉内(IA)化疗前后的可行性和一致性,并将这些数据与临床缓解率进行比较。
本研究纳入了61例患者(平均年龄59.3岁;47例男性),这些患者经组织学证实患有口腔或口咽小癌(局部肿瘤分期为T1/2)。作为多模式治疗方案的一部分,患者接受了高剂量顺铂的IA化疗,并在局部化疗前和化疗后4周接受了临床和放射学检查。
所有患者(61/61)均可行肿瘤反应的临床评估。61例患者中有42例(69%)可行肿瘤体积的放射学评估,但19例(31%)因无深部肿瘤扩散、缺乏对比增强或严重的牙科伪影而评估失败。根据体积和临床标准可行评估的患者显示出可比 的缓解率:总体缓解率分别为54.8%和52.4%,疾病稳定率分别为40.4%和47.6%,肿瘤进展率分别为4.8%和0.0%。
由于约三分之一的患者无法进行体积计算,因此不建议将其作为口腔小癌患者治疗反应的可靠指标。